News

HeliFX Aortic Securement System Aptus Aneurism Repair

Aptus Endosystems Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracic-length HeliFX Aortic Securement System. Similar to the original...

September 21, 2012 — Endologix Inc. announced this month it received CE mark for the current version of the Nellix EndoVascular Aneurysm Sealing System for the...

July 9, 2012 — Endosystems Inc., a medical device company developing technology for endovascular aneurysm repair (EVAR), announced closing on $25 million of equity financing. Synergy Life Science...

June 22, 2012 –– The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by Medtronic Inc. for an early feasibility pilot program that allows for “...

June 8, 2012 — Medtronic Inc. announced the U.S. launch of the Endurant II AAA Stent Graft System, which recently received approval from the U.S. Food and Drug Administration (FDA) for the...

April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scientific meeting, May 17, in Paris.

February 16, 2012 — Aptus Endosystems, a company developing advanced technology for endovascular aneurysm repair (EVAR), announced the start of ANCHOR; a global, multicenter, prospective post-...

January 18, 2011 – Medtronic Inc. announced the CE mark and international launch of the Endurant II AAA stent graft system, which can treat patients with abdominal aortic aneurysms through...

January 17, 2012 — The U.S. Food and Drug Administration (FDA) expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-...

December 22, 2011 — TriVascular Inc. announced the first Canadian patients treated with its Ovation Abdominal Stent Graft. The ultra-low profile (14F OD) system is designed to expand the patient...

December 14, 2011 — Aptus Endosystems Inc. announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the...

December 6, 2011 — W. L. Gore & Associates, Inc. (Gore) has received U.S. Food and Drug Administration (FDA) approval for new diameter sizes of the contralateral leg component of its Excluder...

November 23, 2011 – Vascular occlusions are blocked blood vessels caused by a blood clot in an artery. Blocks in the femoral artery are particularly problematic, and vascular surgeons continue to...

 

November 23, 2011 – The U.S. Food and Drug Administration (FDA) allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to...

November 22, 2011 — The thoracic aorta can pose major problems for endovascular repair when there are tortuous segments. Navigating an endograft through difficult territory can prevent its precise...

November 22, 2011 — The question remains whether patency rates for heparin-bonded polytetrafluoroethylene (PTFE) grafts are better than traditional PTFE bypasses; whether these types of grafts...

November 18, 2011 – W. L. Gore & Associates Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market the Conformable Gore Tag thoracic...

November 4, 2011 — The U.S. Food and Drug Administration (FDA) has approved a stent graft system for patients with small arteries; it will give them the option of less invasive surgery to repair...

August 31, 2011 — Medtronic Inc. announced the start of its United States post-approval study of the Endurant AAA stent graft system, a medical device used to treat abdominal aortic aneurysms (AAA...

August 19, 2011 - Endologix Inc. said a ruling this week will likely aid its defense in a stent graft patent litigation case filed by Cook Medical.